Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial. Arimidex Study Group (Q73190394)
scientific article published on 01 November 2000
Language:
(P31) (Q13442814)
(P304) 3758-3767
(P407) (Q1860)
(P433) 22
(P478) 18
(P577) Wednesday, November 1, 2000
(P921) (Q6934595)
(Q128581)
(Q419143)
(Q412178)
(P1433) (Q400292)
(P1476) "Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial. Arimidex Study Group" (language: en)
(P2093) J M Nabholtz
A Buzdar
M Pollak
W Harwin
G Burton
A Mangalik
M Steinberg
A Webster
M von Euler
other details
description scientific article published on 01 November 2000

External Links